Ultralife (ULBI) Projected to Announce Earnings on Thursday

Ultralife (NASDAQ:ULBI) will likely be issuing its Q2 2026 results before the market opens on Thursday, July 23rd. Analysts expect the company to post earnings of $0.19 per share and revenue of $55.00 million for the quarter. Interested persons can check the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, August 6, 2026 at 12:00 PM ET.

Ultralife (NASDAQ:ULBI) last posted its quarterly earnings results on Friday, May 8th. The technology company reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.15 by ($0.18). Ultralife had a negative net margin of 4.37% and a positive return on equity of 1.15%. The company had revenue of $47.45 million during the quarter, compared to analyst estimates of $52.40 million.

Ultralife Stock Performance

Shares of Ultralife stock opened at $5.44 on Wednesday. The business’s 50 day moving average price is $6.30 and its 200 day moving average price is $6.40. The company has a market cap of $90.63 million, a price-to-earnings ratio of -10.88 and a beta of 0.78. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.23 and a current ratio of 2.56. Ultralife has a one year low of $4.90 and a one year high of $9.52.

Insider Buying and Selling at Ultralife

In other news, Director Bradford T. Whitmore purchased 67,302 shares of the business’s stock in a transaction dated Tuesday, May 26th. The stock was acquired at an average price of $6.81 per share, for a total transaction of $458,326.62. Following the acquisition, the director directly owned 2,050,637 shares of the company’s stock, valued at approximately $13,964,837.97. This represents a 3.39% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Over the last three months, insiders have purchased 108,878 shares of company stock valued at $714,928. Corporate insiders own 42.90% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in ULBI. Bank of America Corp DE raised its position in Ultralife by 30.7% in the fourth quarter. Bank of America Corp DE now owns 12,067 shares of the technology company’s stock valued at $90,000 after purchasing an additional 2,836 shares during the period. Jones Financial Companies Lllp grew its holdings in shares of Ultralife by 1,428.7% during the 1st quarter. Jones Financial Companies Lllp now owns 15,287 shares of the technology company’s stock worth $82,000 after purchasing an additional 14,287 shares during the period. Arrowstreet Capital Limited Partnership grew its holdings in shares of Ultralife by 474.6% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 70,476 shares of the technology company’s stock worth $633,000 after purchasing an additional 58,211 shares during the period. Walleye Capital LLC increased its position in shares of Ultralife by 127.2% during the 2nd quarter. Walleye Capital LLC now owns 31,102 shares of the technology company’s stock worth $279,000 after purchasing an additional 17,414 shares during the last quarter. Finally, Qube Research & Technologies Ltd acquired a new stake in shares of Ultralife during the 2nd quarter worth about $134,000. 30.68% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Weiss Ratings lowered Ultralife from a “sell (d+)” rating to a “sell (d)” rating in a report on Friday, June 12th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of “Sell”.

About Ultralife

Ultralife Corporation (NASDAQ: ULBI) develops, manufactures and sells a broad range of energy and communications products for defense, medical, automotive and consumer electronics markets. The company operates through two primary segments: Power Systems and Communications Systems. In its Power Systems segment, Ultralife produces lithium-ion rechargeable cells and battery packs, primary lithium batteries, alkaline and rechargeable battery packs, chargers and battery accessories designed to meet demanding performance and safety requirements.